We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
+44.04%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$333M
AUM Growth
+$98M
(+42%)
Cap. Flow
+$16.1M
Cap. Flow
% of AUM
4.84%
Top 10 Holdings %
Top 10 Hldgs %
83.38%
Holding
25
New
3
Increased
4
Reduced
5
Closed
4
Top Buys
| 1 |
SLN
Silence Therapeutics
SLN
|
+$22.2M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$12.6M |
| 3 |
ALLK
Allakos
ALLK
|
+$6.88M |
| 4 |
Kura Oncology
KURA
|
+$2.79M |
| 5 |
Madrigal Pharmaceuticals
MDGL
|
+$2.08M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
+$13.9M |
| 2 |
Geron
GERN
|
+$6.67M |
| 3 |
ETNB
89bio
ETNB
|
+$3.65M |
| 4 |
Viridian Therapeutics
VRDN
|
+$2.7M |
| 5 |
ALPN
Alpine Immune Sciences Inc
ALPN
|
+$2.67M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
1
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $69.6M | 20.87% |
3,877,903
+963,653
| +33% | +$12.6M |
|
2
Cogent Biosciences
COGT
$6.48B
| $51.9M | 15.58% |
3,481,042
| – | – |
|
|
3
Geron
GERN
$911M
| $28.4M | 8.5% |
12,115,926
-2,980,416
| -20% | -$6.67M |
|
|
4
Viridian Therapeutics
VRDN
$1.99B
| $23.9M | 7.16% |
1,164,000
-150,000
| -11% | -$2.7M |
|
|
SLN
5
Silence Therapeutics
SLN
$516M
| $21.1M | 6.34% |
+2,104,875
| New | +$22.2M |
|
|
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
| $20.7M | 6.2% |
5,905,400
| – | – |
|
|
7
Kura Oncology
KURA
$967M
| $18.4M | 5.53% |
1,348,642
+181,000
| +16% | +$2.79M |
|
8
Aclaris Therapeutics
ACRS
$749M
| $18M | 5.41% |
1,144,939
| – | – |
|
|
JBIO
9
Jade Biosciences
JBIO
$1.25B
| $15.9M | 4.77% |
27,416
+2,000
| +8% | +$1.34M |
|
10
Entrada Therapeutics
TRDA
$267M
| $10.1M | 3.04% |
642,189
-21,505
| -3% | -$273K |
|
|
ALLK
11
DELISTED
Allakos
ALLK
| $10.1M | 3.02% |
+1,643,500
| New | +$6.88M |
|
|
AKUS
12
DELISTED
Akouos Inc
AKUS
| $9.13M | 2.74% |
1,350,006
| – | – |
|
13
Tyra Biosciences
TYRA
$1.88B
| $8.31M | 2.49% |
945,707
+49,289
| +5% | +$451K |
|
14
MoonLake Immunotherapeutics
MLTX
$1.59B
| $7.76M | 2.33% |
1,000,000
| – | – |
|
|
MRUS
15
DELISTED
Merus
MRUS
| $6.01M | 1.8% |
300,000
| – | – |
|
16
Tango Therapeutics
TNGX
$4.5B
| $4.24M | 1.27% |
1,172,250
| – | – |
|
17
Dianthus Therapeutics
DNTH
$5.21B
| $3M | 0.9% |
132,758
| – | – |
|
18
Zai Lab
ZLAB
$2.34B
| $2.49M | 0.75% |
72,777
-22,223
| -23% | -$951K |
|
|
19
Madrigal Pharmaceuticals
MDGL
$12.6B
| $1.95M | 0.58% |
+30,000
| New | +$2.08M |
|
|
ALPN
20
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.83M | 0.55% |
254,569
-323,691
| -56% | -$2.67M |
|
|
ELEV
21
DELISTED
Elevation Oncology
ELEV
| $627K | 0.19% |
555,000
| – | – |
|
22
AnaptysBio
ANAB
$1.6B
| – | – |
-58,515
| Closed | -$1.19M |
|
|
ETNB
23
DELISTED
89bio
ETNB
| – | – |
-1,133,196
| Closed | -$3.65M |
|
|
PRDS
24
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
| – | – |
-59,039
| Closed | -$181K |
|
|
KDNY
25
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| – | – |
-796,460
| Closed | -$13.9M |
|
Similar funds
DILIC
IIM
KCM
ACM
BCP
AL
ACA
MSC